Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

AstraZeneca's BTK inhibitor Calquence has become the first drug in the class to be approved by the US FDA as a treatment for adult patients with previously untreated mantle cell lymphoma (MCL ...